Status:
TERMINATED
Assessing the Effectiveness of an N-of-1 Platform Using Study of Cognitive Enhancers
Lead Sponsor:
Icahn School of Medicine at Mount Sinai
Conditions:
Cognitive Performance
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The growing consumer-grade molecular and digital wellness market is generating unprecedented volumes of information to support decision-making around individual health. Current trends suggest the dema...
Detailed Description
The growing burden of chronic disease in the U.S. and the economics of accountable care are driving a shift toward proactive approaches to disease prevention and health maintenance. At the same time, ...
Eligibility Criteria
Inclusion
- US resident
- 18 years old or over
- Has an iPhone
- Regular caffeine drinker
Exclusion
- Pregnant/breastfeeding
- Any contraindication/health issue in which risk is added by consumption of caffeine
Key Trial Info
Start Date :
October 18 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 22 2020
Estimated Enrollment :
57 Patients enrolled
Trial Details
Trial ID
NCT04056650
Start Date
October 18 2019
End Date
December 22 2020
Last Update
March 12 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Icahn School of Medicine at Mount Sinai
New York, New York, United States, 10029